We believe Prestige is in fine financial health. At the end of fiscal 2024, the company had roughly $46 million in cash and equivalents with about $1.1 billion in long-term debt. Majority of debt was ...

Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...

Prestige Consumer Healthcare Inc.’s PBH share price has surged by 14.78%, which has investors questioning if this is right ...

Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

In an era where wellness and natural health are paramount, CBD products have surged in popularity, captivating the attention ...

The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...

What happened to Darvon? It wasn’t addicting and didn’t cost much, and I never heard any reason why it was withdrawn except that “it didn’t work.” It ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...